Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer
Significant number of prostate tumors are slow growing and could probably be left untreated. However, many are aggressive and can spread rapidly causing patient suffering and/or death. Current technology does not allow physicians to differentiate between slow growing and aggressive tumors at diagnos...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2011-05-01
|
Series: | American Journal of Men's Health |
Online Access: | https://doi.org/10.1177/1557988310390030 |
_version_ | 1828400923578204160 |
---|---|
author | Amit M. Algotar PhD, MBBS Steven P. Stratton PhD James Ranger-Moore PhD M. Suzanne Stratton PhD C.H. Hsu PhD Frederick R. Ahmann MD Raymond B. Nagle MD, PhD Patricia A. Thompson PhD |
author_facet | Amit M. Algotar PhD, MBBS Steven P. Stratton PhD James Ranger-Moore PhD M. Suzanne Stratton PhD C.H. Hsu PhD Frederick R. Ahmann MD Raymond B. Nagle MD, PhD Patricia A. Thompson PhD |
author_sort | Amit M. Algotar PhD, MBBS |
collection | DOAJ |
description | Significant number of prostate tumors are slow growing and could probably be left untreated. However, many are aggressive and can spread rapidly causing patient suffering and/or death. Current technology does not allow physicians to differentiate between slow growing and aggressive tumors at diagnosis. Hence, many patients are exposed to invasive treatment and its associated morbidities such as incontinence and impotence. Markers that enable differentiation between slow and fast progressing cancer will allow physicians to prevent unnecessary treatments on men who may not need them, and focus on the men with aggressive disease. A longitudinal study was conducted ( N = 140) using mixed effects regression models to determine the association of obesity and smoking toward prostate cancer progression. These models account for correlation because of repeated measures over time, thus, using maximum amount of information provided by the subject. Estimates thus obtained are more robust and reliable than those obtained using data from a single time point. Rate of change of prostate-specific antigen (PSA) over time (PSA velocity) was used as a measure of prostate cancer progression. Results indicate that PSA velocity of overweight and obese subjects (0.59 and 1.05 ng/mL/year) was not significantly different as compared with normal weight subjects ( p values .91 and .31, respectively). For men in the highest tertile of pack-years of smoking, PSA velocity was significantly higher as compared with never smokers 1.57 ng/mL/year ( p = .04). Further studies with larger sample sizes and study designs specific to above exposures are needed before recommendations can be made to reduce weight or reduce/quit smoking. |
first_indexed | 2024-12-10T09:38:58Z |
format | Article |
id | doaj.art-8e665e97e1204deba9a8d9fd8d6fee53 |
institution | Directory Open Access Journal |
issn | 1557-9883 |
language | English |
last_indexed | 2024-12-10T09:38:58Z |
publishDate | 2011-05-01 |
publisher | SAGE Publishing |
record_format | Article |
series | American Journal of Men's Health |
spelling | doaj.art-8e665e97e1204deba9a8d9fd8d6fee532022-12-22T01:54:04ZengSAGE PublishingAmerican Journal of Men's Health1557-98832011-05-01510.1177/1557988310390030Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate CancerAmit M. Algotar PhD, MBBSSteven P. Stratton PhDJames Ranger-Moore PhDM. Suzanne Stratton PhDC.H. Hsu PhDFrederick R. Ahmann MDRaymond B. Nagle MD, PhDPatricia A. Thompson PhDSignificant number of prostate tumors are slow growing and could probably be left untreated. However, many are aggressive and can spread rapidly causing patient suffering and/or death. Current technology does not allow physicians to differentiate between slow growing and aggressive tumors at diagnosis. Hence, many patients are exposed to invasive treatment and its associated morbidities such as incontinence and impotence. Markers that enable differentiation between slow and fast progressing cancer will allow physicians to prevent unnecessary treatments on men who may not need them, and focus on the men with aggressive disease. A longitudinal study was conducted ( N = 140) using mixed effects regression models to determine the association of obesity and smoking toward prostate cancer progression. These models account for correlation because of repeated measures over time, thus, using maximum amount of information provided by the subject. Estimates thus obtained are more robust and reliable than those obtained using data from a single time point. Rate of change of prostate-specific antigen (PSA) over time (PSA velocity) was used as a measure of prostate cancer progression. Results indicate that PSA velocity of overweight and obese subjects (0.59 and 1.05 ng/mL/year) was not significantly different as compared with normal weight subjects ( p values .91 and .31, respectively). For men in the highest tertile of pack-years of smoking, PSA velocity was significantly higher as compared with never smokers 1.57 ng/mL/year ( p = .04). Further studies with larger sample sizes and study designs specific to above exposures are needed before recommendations can be made to reduce weight or reduce/quit smoking.https://doi.org/10.1177/1557988310390030 |
spellingShingle | Amit M. Algotar PhD, MBBS Steven P. Stratton PhD James Ranger-Moore PhD M. Suzanne Stratton PhD C.H. Hsu PhD Frederick R. Ahmann MD Raymond B. Nagle MD, PhD Patricia A. Thompson PhD Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer American Journal of Men's Health |
title | Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer |
title_full | Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer |
title_fullStr | Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer |
title_full_unstemmed | Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer |
title_short | Association of Obesity and Smoking With PSA and PSA Velocity in Men With Prostate Cancer |
title_sort | association of obesity and smoking with psa and psa velocity in men with prostate cancer |
url | https://doi.org/10.1177/1557988310390030 |
work_keys_str_mv | AT amitmalgotarphdmbbs associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer AT stevenpstrattonphd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer AT jamesrangermoorephd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer AT msuzannestrattonphd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer AT chhsuphd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer AT frederickrahmannmd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer AT raymondbnaglemdphd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer AT patriciaathompsonphd associationofobesityandsmokingwithpsaandpsavelocityinmenwithprostatecancer |